Finance Business Partner - Immunology Portfolio (Non Alliance) and Integration Projects

Role Summary

Location: Morristown, NJ; Cambridge, MA. Finance Partner for the Immunology Portfolio (Non Alliance) and Integration Projects. This role serves as the financial architect behind the Immunology growth strategy, guiding new launches and the integration of acquisitions. You will partner with cross-functional teams to optimize investments, drive Net Revenue and BOI objectives, and enable sustainable growth across launches and integration initiatives.

Responsibilities

• Lead financial strategy and business partnering for Amlitelimab, Immunology new launches, and integration activities
• Serve as primary finance partner guiding strategic decisions to achieve Net Revenue and BOI objectives
• Provide thought leadership and financial oversight, applying critical thinking to optimize value and manage risks
• Align financial and business strategies by partnering with stakeholders to evaluate investment trade-offs
• Own full P&L responsibility including revenue planning, headcount, and operating expense controlling
• Lead annual Budget, Forecast, and Strategic Plan processes with timelines and data validation
• Oversee daily financial operations including inventory management, cash flow, and pricing dynamics
• Anticipate and assess financial impact of business decisions across the full P&L
• Direct month-end close processes including sales analysis, GTN deductions, expense assessment, journal entries, balance sheet review
• Deliver timely financial reporting, variance analysis, and business performance commentary
• Drive monthly sales trend analysis with Commercial, Forecasting, and Data Analytics teams
• Conduct in-depth Gross-to-Net analysis including balance sheet provisions and risk assessment
• Define, monitor, and report key KPIs and launch readiness metrics
• Partner with cross-functional teams to integrate financial processes for newly acquired business
• Support business cases, scenario planning, and launch readiness assessments
• Ensure cross-functional alignment and proactive risk mitigation for new launches
• Supervise and lead Opex and Revenue Controllers overseeing commercial sales and operating expense budgets
• Collaborate with AI and Commercial Analytics teams to enhance forecast models
• Integrate AI capabilities to monitor sales trends and improve forecasting accuracy
• Support finance system enhancements and digital transformation initiatives
• Present financial analyses to Senior Leadership including US & Global teams, Head of NA SPC, and Executive Leadership
• Support internal controls and external audit requirements
• Promote finance best practices in partnership with One-Finance
• Actively collaborate with Sales & Marketing, Market Access, Patient Services, Supply Chain, and Business Operations
• Key business partners: US Immunology General Manager; Franchise Leads: Amlitelimab and Integration Workstreams; Sales Leadership, Marketing, and Patient Support Services; Market Access and Business Operations (Forecasting & Analytics); Global Supply Chain; Global Finance and One-Finance; Alliance Partners (as applicable)

Qualifications

• Bachelor's degree in Finance, Accounting, or related field - Required
• 5+ years of progressive finance experience - Required
• CPA or MBA - Preferred
• Pharmaceutical industry controlling experience - Preferred
• Strong understanding of financial concepts including Revenue and Expense controlling - Required
• Proven experience in Gross-to-Net forecasting and analysis - Required
• Proficiency with SAP, Hyperion, TM1 Cognos - Required
• Advanced Excel skills (pivot tables, VLOOKUPs, macros, data analysis) - Required
• Demonstrated business partnering ability in complex matrix organizations - Required

Skills

• Strategic thinker with strong analytical and problem-solving skills
• Exceptional leadership qualities with ability to influence senior stakeholders
• Strong business acumen and commercial orientation
• Effective communicator with executive presence
• Results-driven with focus on operational excellence
• Ability to adapt priorities in a fast-paced environment
• Ability to synthesize macroeconomic, industry, and internal data to shape strategy